You'll see patients getting Arimidex for EARLY breast cancer

October 2002

You'll see patients getting Arimidex for EARLY breast cancer.

Arimidex (anastrozole) just got approved in the U.S. for early breast cancer. Health Canada is considering it.

Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

attention being focused on hepatitis
Cardiology whether Atacand is more effective than Cozaar
Cardiology role of infections in cardiovascular disease
Hematology & Oncology Gleevec (imatinib) for a certain kind of stomach cancer
Hematology & Oncology You'll see patients getting Arimidex for EARLY breast cancer
Pediatrics More adolescents are now being treated for depression
Infectious Diseases young children getting flu shots this year
Infectious Diseases differences between the new Biaxin XL and regular Biaxin (clarithromycin) tablets
Diabetes Avapro or Cozaar for kidney disease
Gastroenterology yogurt for H. pylori
Gastroenterology use of proton pump inhibitors in children
psychiatric side effects from Lariam (mefloquine)
Natural Medicines Super Blue Stuff, a topical gel widely promoted on the Internet for pain and arthritis
how to treat ADHD in adults
Does ginkgo really improve memory?